Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

102.400
+1.2001.19%
Volume:15.25M
Turnover:1.56B
Market Cap:178.59B
PE:186.77
High:104.000
Open:101.800
Low:100.600
Close:101.200
52wk High:109.100
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:1.10
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:5.01%
ROA:1.56%
PB:7.91
PE(LYR):186.77
PS:11.74

Loading ...

Hong Kong Market Rises; LENOVO GROUP Surges to New Highs, Property and Biotech Stocks Shine

Stock News
·
May 29

Hong Kong Stocks Rebound on U.S.-Iran Truce Talks; Creality 3D Technology Jumps on Debut

MT Newswires Live
·
May 29

INNOVENT BIO and Pfizer Forge $10.5 Billion Oncology Partnership, Sparking 7% Stock Surge

Deep News
·
May 29

INNOVENT BIO Surges Nearly 9% Following $10.5 Billion Global Partnership Agreement with Pfizer

Stock News
·
May 29

Stock Track | INNOVENT BIO Soars 6.95% Intraday on $10.5 Billion Global Oncology Collaboration with Pfizer

Stock Track
·
May 29

Movement Alert|Innovent Biologics Rises 9.15% in Regular Trading, Signs $10.5 Billion Global Strategic Partnership with Pfizer

Market Focus
·
May 29

Innovent Strikes Up to US$10.5 Billion Global Oncology Pact With Pfizer

TIPRANKS
·
May 29

China and US Agree in Principle to Discuss Reciprocal Tariff Reduction Framework; State Council Issues Urban Renewal 15th Five-Year Plan

Stock News
·
May 29

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Reuters
·
May 29

Pfizer, Innovent Sign Licensing Deal to Develop 12 Cancer Drugs

Dow Jones
·
May 29

BRIEF-Pfizer And Innovent Biologics Enter Global Strategic Collaboration To Accelerate Development Of Innovative Oncology Medicines

Reuters
·
May 29

Innovent signs up to US$10.50 billion global oncology pact with Pfizer

Bulletin Express
·
May 29

Pfizer - and Innovent Enter Global Licensing and Collaboration for 12 Cancer Medicines

THOMSON REUTERS
·
May 29

Pfizer - Innovent to Receive $650 Mln Upfront and up to $9.85 Bln in Milestones

THOMSON REUTERS
·
May 29

INNOVENT BIO (01801) and Pfizer Forge Global Strategic Alliance to Expedite Novel Oncology Drug Development

Stock News
·
May 29

Innovent partners with Pfizer in oncology R&D deal worth up to USD 10.5 billion

Reuters
·
May 29

Innovent Biologics - to Receive $650 Mln Upfront, Deal Value up to $10.5 Bln

THOMSON REUTERS
·
May 29

Innovent Biologics - Enters Global Strategic Collaboration With Pfizer for 12 Oncology Programs

THOMSON REUTERS
·
May 29

Innovent Biologics - to Receive up to Double-Digit Royalties on Sales of Approved Products

THOMSON REUTERS
·
May 29

Innovative Drug Stocks Decline in Hong Kong Amid Rate Hike Expectations and ASCO Conference Focus

Stock News
·
May 28